Get the Stockscreener App
15.97
0.19%
-0.03
After Hours:
15.92
-0.05
-0.31%
Electrocore Inc stock is traded at $15.97, with a volume of 93,638.
It is down -0.19% in the last 24 hours and down -11.23% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$16.00
Open:
$15.77
24h Volume:
93,638
Relative Volume:
0.76
Market Cap:
$106.30M
Revenue:
$16.03M
Net Income/Loss:
$-18.83M
P/E Ratio:
-4.5629
EPS:
-3.5
Net Cash Flow:
$-14.87M
1W Performance:
+1.65%
1M Performance:
-11.23%
6M Performance:
+174.87%
1Y Performance:
+120.12%
1-Day Range:
$15.31
$16.25
1-Week Range:
$15.15
$16.95
52-Week Range:
$5.32
$18.67
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
15.97 | 106.30M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
electroCore secures two new US patents for nerve therapy By Investing.com - Investing.com South Africa
electroCore secures two new US patents for nerve therapy - Investing.com
electroCore Expands Intellectual Property Portfolio - GlobeNewswire
Breakthrough Patents Bolster electroCore's Nerve Stimulation Tech: Smart Monitoring Meets Precision Treatment - StockTitan
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewswire
Exclusive: electroCore Leadership Takes Center Stage at Elite BTIG Healthcare Summit - StockTitan
Short Interest in electroCore, Inc. (NASDAQ:ECOR) Drops By 22.8% - MarketBeat
Insider Stock Buying Reaches US$675.8k On electroCore - Yahoo Finance UK
Here's Why Momentum in electroCore (ECOR) Should Keep going - Yahoo Finance
When the Price of (ECOR) Talks, People Listen - Stock Traders Daily
Vagus Nerve Stimulators Market is Estimated to Grow at a CAGR - openPR
electroCore (NASDAQ:ECOR) Announces Preliminary Financial Results for Q4 2024 and Full Year - Defense World
Short Interest in electroCore, Inc. (NASDAQ:ECOR) Decreases By 22.8% - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
electroCore: An Opportunity In Medical And Wellness Device Innovation (NASDAQ:ECOR) - Seeking Alpha
electroCore, Inc.'s (NASDAQ:ECOR) last week's 14% decline must have disappointed individual investors who have a significant stake - Simply Wall St
Geode Capital Management LLC Raises Stock Holdings in electroCore, Inc. (NASDAQ:ECOR) - Defense World
Contrasting CONMED (NYSE:CNMD) & electroCore (NASDAQ:ECOR) - Defense World
International Assets Investment Management LLC Has $895,000 Holdings in electroCore, Inc. (NASDAQ:ECOR) - MarketBeat
electroCore announces 5 new U.S. patents - MSN
electroCore Receives 5 New U.S. Patents - MPO-mag
electroCore Secures 5 Groundbreaking Patents for Nerve Stimulation Medical Breakthroughs - StockTitan
ElectroCore stock soars to 52-week high, hits $17.98 By Investing.com - Investing.com South Africa
ElectroCore stock soars to 52-week high, hits $17.98 - Investing.com
electroCore, Inc.'s (NASDAQ:ECOR) largest shareholders are individual investors with 58% ownership, insiders own 22% - Yahoo Finance
Here’s Why Rogue Funds is Excited on Electrocore (ECOR) - Insider Monkey
electroCore Inc (ECOR) Shares Gap Down to $16.07 on Dec 31 - GuruFocus.com
electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM (ECOR) - Seeking Alpha
HighTower Advisors LLC Buys New Holdings in electroCore, Inc. (NASDAQ:ECOR) - Defense World
HighTower Advisors LLC Acquires Shares of 35,342 electroCore, Inc. (NASDAQ:ECOR) - MarketBeat
Q2 Earnings Estimate for electroCore Issued By HC Wainwright - Defense World
HC Wainwright Has Optimistic View of electroCore Q2 Earnings - MarketBeat
electroCore FY2026 EPS Estimate Increased by HC Wainwright - Defense World
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
HC Wainwright Predicts Increased Earnings for electroCore - MarketBeat
Vagus Nerve Stimulators Market Report Analysis and Research - openPR
ElectroCore stock soars to 52-week high, hits $15.37 By Investing.com - Investing.com South Africa
electroCore to acquire NeuroMetrix - Medical Buyer
Electrocore powers up with Neurometrix acquisition - BioWorld Online
Why Investors Shouldn't Be Surprised By electroCore, Inc.'s (NASDAQ:ECOR) 27% Share Price Surge - Simply Wall St
electroCore announces acquisition of Neurometrix - MSN
ElectroCore shares target increased, buy rating on NeuroMetrix deal By Investing.com - Investing.com South Africa
ElectroCore shares target increased, buy rating on NeuroMetrix deal - Investing.com
ElectroCore stock soars to 52-week high, hits $15.37 - Investing.com
electroCore to Acquire Neurotech Company NeuroMetrix - MPO-mag
HC Wainwright Issues Positive Forecast for electroCore (NASDAQ:ECOR) Stock Price - MarketBeat
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):